Gel Documentation Systems Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR (2024 - 2029) | 4.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Gel Documentation Systems Market Analysis
The Gel Documentation Systems Market is expected to register a CAGR of 4.10% during the forecast period.
Factors such as the prevalence of infectious diseases and genetic disorders and increasing research investments in genomics and proteomics techniques are boosting the growth of the gel documentation systems market.
With the growing number of cancer cases worldwide, the demand for gel documentation systems for research applications is expected to increase. For instance, according to the report published by the Australia Institute of Health and Welfare, in August 2023, about 162,000 new cancer cases were diagnosed in Australia in 2022, which rose to over 165,000 in 2023. As per the same source, prostate cancer, colorectal cancer, and lung cancer were the most frequently diagnosed cancers. The increase in cancer diagnoses, particularly prostate, colorectal, and lung cancers, is driving the growth of the gel documentation systems market by necessitating advanced tools for accurate molecular and genetic analysis in cancer research and diagnostics.
Additionally, research collaborations are increasing, which is also expected to boost the demand for gel documentation systems. For example, in February 2023, the University of Texas MD Anderson Cancer Center announced a strategic collaboration with biotech company Xilis to accelerate the development of novel cancer therapies using Xilis' proprietary MicroOrganoSphere (MOS) technology. The growing trend of research collaborations is anticipated to significantly enhance the demand for gel documentation systems, driven by the need for advanced technologies in the development of innovative cancer therapies.
Moreover, in January 2022, Eli Lilly and Company acquired exclusive rights to Entos Pharmaceuticals' Fusogenix nucleic acid delivery technology. This acquisition would allow both companies to initiate the research, development, and commercialization of nucleic acid products that target the central and peripheral nervous systems. Eli Lilly will have access to a novel delivery platform technology that can address the challenges of nucleic acid therapeutic modalities, thus contributing to the market's growth. Such developments are expected to increase the demand for research on nucleic acids and proteins, which require gel documentation systems, thus driving the market's growth.
In conclusion, the gel documentation systems market is anticipated to grow over the analysis period due to the increasing prevalence of diseases and research developments. However, the growing adoption of alternative techniques may impede the market's growth.
Gel Documentation Systems Market Trends
Nucleic Acid Quantification is Expected to Register Considerable Growth Over the Forecast Period
Nucleic acid quantification is a technique used to determine the amount of nucleic acid present in a solution by using gel electrophoresis to separate the target nucleic acid band according to the molecular weight of the nucleic acid segments in the band. The quantity of the target nucleic acid band is determined by visualizing the nucleic acid bands under a gel documentation system and comparing them with the nucleic acid ladder. This technique is essential for various research studies involving the determination of the molecular weight of nucleic acids such as DNA and RNA. It has several applications in amplification, genetic engineering, and other fields.
Recent studies have highlighted the importance of nucleic acid quantitation in disease management, particularly in the case of viral infections such as HIV-1 and SARS-CoV2. For instance, a report published by the Journal Methods in May 2022 emphasized the significance of sensitive detection and quantitation of viral nucleic acids for disease management. The study demonstrated that sensitive HIV-1 DNA and RNA quantitation assays can aid in effectively treating and managing HIV-1 infection, including combination antiretroviral therapy (cART).
The high usage of nucleic acid quantification using gel electrophoresis, which requires gel documentation systems, is expected to drive the growth of the nucleic acid quantification segment. Furthermore, research investments in HIV have increased, which is also expected to drive the demand for gel documentation systems for HIV-related studies. According to data published by the United States Department of Health & Human Services in October 2022, the National Institute of Health (NIH) announced 66 awards to institutions participating in the NIMH AIDS Research Centers (ARC) programs and NIH-funded Centers for AIDS Research (CFAR) as part of the initiative to "End the HIV Epidemic in the United States (EHE)." The increasing need for nucleic acid quantification in gel electrophoresis and heightened research efforts in HIV are anticipated to significantly drive the demand for gel documentation systems.
Therefore, due to the importance and various applications of nucleic acid quantitation in research studies, as well as the increased demand for gel documentation systems for HIV-related studies, the nucleic acid quantification segment is expected to grow significantly over the forecast period.
North America is Expected to Witness Significant Growth Over the Forecast Period
North America is expected to witness significant growth over the forecast period, owing to the high prevalence of chronic diseases, advanced healthcare infrastructure, and research investments. The increasing prevalence of chronic diseases in the region would create more demand for diagnosis and research of the target protein, biomarkers, and nucleic acid, which utilizes gel documentation systems for visualizing the protein/nucleic acid bands. For instance, a report published by the American Cancer Society in January 2023 reported that new cases of prostate cancer, cervical cancer, and bladder cancer constituted 14.7%, 0.7%, and 4.2%, respectively, of the 1.9 million new cancer diagnoses in the United States for that year.
Further, according to the Canadian Cancer Society's 2023 data, 233,900 new cancer cases were reported in 2022. Concurrently, the region is experiencing a significant burden of diabetes, which is expected to increase the demand for gel documentation systems utilized in research. The Canadian Diabetes Association reported in June 2022 that over 5.7 million Canadians were diagnosed with either type 1 or type 2 diabetes in 2022.
Furthermore, the region has significant investments in cancer and other diseases, which would create more demand for the gel documentation system as they are used in imaging the electrophoresis gel to study the target protein. Thus, the increasing research in the North American region is expected to boost the growth of the gel documentation market.
For instance, in January 2023, the Canadian Institutes of Health Research of the Government of Canada (CIHR) invested over CAD 23 million (USD 16.83 million) into pediatric cancer in Canada. Further, in December 2022, Breast Cancer Canada announced a call for proposals for its 2023 Precision Oncology Research Grants, which would award over CAD 500,000 (USD 36,600) in its new funding for breast cancer research projects.
The key developments and investments into research in the region are expected to create more demand for the gel documentation system for the research, which would boost the market in the region. For instance, in May 2023, the Lung Cancer Research Foundation (LCRF) collaborated with Daiichi Sankyo and AstraZeneca. Under the collaboration, LCRF and companies would fund three research grants focused on antibody-drug conjugates to improve the outcomes for lung cancer patients.
Further, in January 2023, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine of the United States planned to invest in six new projects, which are focused on breast, prostate, neck and head cancer, lung, osteosarcoma, and neuroblastoma. Also, in January 2022, Novartis planned to invest over USD 50 million into clinical research in Mexico. The investment would strengthen the discovery of new drugs for diseases with unmet medical needs in the country and, thus, create the demand for gel documentation systems and accessories and drive the market's growth.
Therefore, owing to the factors above, including the increasing prevalence of diseases and increasing research investment into diseases, the growth of the market studied is anticipated in North America.
Gel Documentation Systems Industry Overview
The gel documentation systems market is fragmented in nature, with the presence of major players in the market. Collaborations, mergers, and acquisitions by companies related to gel documentation are expected to boost market growth. Some of the companies that are currently dominating the GI stool testing market are Bio-Rad Laboratories, Inc., Syngene, Thermo Fisher Scientific, Cleaver Scientific Ltd, and Merck KGaA.
Gel Documentation Systems Market Leaders
-
Bio-Rad Laboratories, Inc.
-
Syngene
-
Thermo Fisher Scientific
-
Cleaver Scientific Ltd
-
Merck KGaA
*Disclaimer: Major Players sorted in no particular order
Gel Documentation Systems Market News
- June 2024: Syngene introduced the PXi, a high-resolution image analysis system, to its product portfolio. This advanced system stands out as the best in its class, providing scientists with a compact and user-friendly solution for accurately imaging chemiluminescent and fluorescent blots, as well as 1-D gels up to 10cm x 12cm stained with any type of fluorescent dye.
- May 2024: Bio-Rad Laboratories launched its ChemiDoc Go imaging system for chemiluminescence sensitivity. The ChemiDoc Go Imaging System, equipped with advanced scientific CMOS digital imaging technology, delivers exceptional sensitivity and maintains a useful linear range without compromise.
Gel Documentation Systems Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumption and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Incidence of Chronic, Infectious Diseases and Genetic Disorders
- 4.2.2 Increasing Research Investment into the Genomic, Proteomics Techniques
-
4.3 Market Restraints
- 4.3.1 Growing Adoption of Alternative Techniques
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Products
- 5.1.1 Instruments
- 5.1.2 Software
- 5.1.3 Accessories
-
5.2 By Light Source
- 5.2.1 Light Emmiting Diodes
- 5.2.2 UV
- 5.2.3 Laser
-
5.3 By Detection Techniques
- 5.3.1 Ultraviolet
- 5.3.2 Chemiluminescence
- 5.3.3 Fluroscence
-
5.4 By Application
- 5.4.1 Nucleic Acid Quantification
- 5.4.2 Protein Quantification
- 5.4.3 Other Applications
-
5.5 By End User
- 5.5.1 Diagnostic Labs
- 5.5.2 Pharamceutical Companies
- 5.5.3 Other End Users
-
5.6 By Geography
- 5.6.1 North America
- 5.6.1.1 United States
- 5.6.1.2 Canada
- 5.6.1.3 Mexico
- 5.6.2 Europe
- 5.6.2.1 Germany
- 5.6.2.2 United Kingdom
- 5.6.2.3 France
- 5.6.2.4 Italy
- 5.6.2.5 Spain
- 5.6.2.6 Rest of Europe
- 5.6.3 Asia-Pacific
- 5.6.3.1 China
- 5.6.3.2 Japan
- 5.6.3.3 India
- 5.6.3.4 Australia
- 5.6.3.5 South Korea
- 5.6.3.6 Rest of Asia-Pacific
- 5.6.4 Middle East and Africa
- 5.6.4.1 GCC
- 5.6.4.2 South Africa
- 5.6.4.3 Rest of Middle East and Africa
- 5.6.5 South America
- 5.6.5.1 Brazil
- 5.6.5.2 Argentina
- 5.6.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Bio-Rad Laboratories Inc.
- 6.1.2 Thermo Fisher Scientific
- 6.1.3 Syngene
- 6.1.4 Cleaver Scientific Ltd
- 6.1.5 Merck KGaA
- 6.1.6 Corning Incorporated
- 6.1.7 Labnet International Inc.
- 6.1.8 Azure Biosystems Inc.
- 6.1.9 Isogen Life Science
- 6.1.10 Analytik Jena AG
- 6.1.11 OPRL Biosciences Pvt. Ltd
- 6.1.12 TechnoSource
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityGel Documentation Systems Industry Segmentation
As per the scope of the report, the gel documentation system is a gel analysis tool used on digital platforms to monitor and quantify stained agarose gel and acrylamide gels. This device has a comprehensive application for the documentation and imaging of proteins and nucleic acid stained in agarose gels in molecular biology laboratories and clinical research centers.
The gel documentation systems market is segmented by product, detection techniques, light source, application, end user, and geography. The product segment is further segmented into instruments, software, and accessories. The detection techniques are further divided into light-emitting diodes, UV, and laser. The light source segment is further bifurcated into ultraviolet, chemiluminescence, and fluorescence. The application segment is further segmented into nucleic acid quantification, protein quantification, and other applications. The end user segment is further divided into diagnostic labs, pharmaceutical companies, and other end users. The geography segment is further segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (USD) for the above segments.
| By Products | Instruments | |
| Software | ||
| Accessories | ||
| By Light Source | Light Emmiting Diodes | |
| UV | ||
| Laser | ||
| By Detection Techniques | Ultraviolet | |
| Chemiluminescence | ||
| Fluroscence | ||
| By Application | Nucleic Acid Quantification | |
| Protein Quantification | ||
| Other Applications | ||
| By End User | Diagnostic Labs | |
| Pharamceutical Companies | ||
| Other End Users | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Gel Documentation Systems Market Research FAQs
What is the current Gel Documentation Systems Market size?
The Gel Documentation Systems Market is projected to register a CAGR of 4.10% during the forecast period (2024-2029)
Who are the key players in Gel Documentation Systems Market?
Bio-Rad Laboratories, Inc., Syngene, Thermo Fisher Scientific, Cleaver Scientific Ltd and Merck KGaA are the major companies operating in the Gel Documentation Systems Market.
Which is the fastest growing region in Gel Documentation Systems Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Gel Documentation Systems Market?
In 2024, the North America accounts for the largest market share in Gel Documentation Systems Market.
What years does this Gel Documentation Systems Market cover?
The report covers the Gel Documentation Systems Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gel Documentation Systems Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Gel Documentation Systems Industry Report
Statistics for the 2024 Gel Documentation Systems market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Gel Documentation Systems analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
